Caleb Ho, MD, Pathology, New York, NY, Memorial Sloan-Kettering Cancer Center

CalebHoMD

Pathology New York, NY

Hematopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology

Assistant Attending, Hematopathology and Diagnostic Molecular Pathology

Dr. Ho is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ho's full profile

Already have an account?

Education & Training

  • Memorial Sloan-Kettering Cancer Center
    Memorial Sloan-Kettering Cancer CenterFELLOWSHIP
  • Brigham and Women's Hospital
    Brigham and Women's HospitalFELLOWSHIP
  • Yale-New Haven Hospital
    Yale-New Haven HospitalRESIDENCY
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAMEDICAL_SCHOOL

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2016 - 2021
  • MA State Medical License
    MA State Medical License 2014 - 2019
  • American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • American Board of Pathology Pathology - Hematology
  • American Board of Pathology Pathology - Molecular Genetic

Publications & Presentations

PubMed

Abstracts/Posters

  • Annotation of Somatic Genomic Variants in Hematologic Diseases Using OncoKB, a Precision Oncology Knowledgebase
    Caleb Ho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Multiple Myeloma Patients Treated with Lenalidomide Maintenance Therapy: A Clinical and Correlative Ph...
    Caleb Ho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Multiple Myeloma Patients Treated with Lenalidomide Maintenance Therapy: A Clinical and Correlative Ph...
    Caleb Ho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Plasma Cell Myeloma Residual Disease Quantitation Using a Next-Generation Sequencing-Based IGH Clonal Rearrangement Assay with the Aid of a Spike-in Clonal Sequence 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • MRD-Response Driven Phase I/II Study for Newly Diagnosed Multiple Myeloma Patients Using Higher Doses of Twice-Weekly Carfilzomib (45 and 56 mg/m2) in Combination with... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Professional Memberships

Other Languages

  • Chinese (Cantonese)

Hospital Affiliations